Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy

Abroad (travel likely)Recruiting

Conditions

Lymphoma · Myeloma · Cytokine Release Syndrome · Immune Effector Cell Associated Neurotoxicity Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah, United States
Contact: Study coordinator (Douglas Sborov, MD, MS) · Douglas.Sborov@hci.utah.edu · 801-585-3229

Study leads

Douglas Sborov, MD, MS
Principal Investigator
Huntsman Cancer Institute/ University of Utah

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma

Recurrent B-Cell Non-Hodgkin Lymphoma · Recurrent Multiple Myeloma · Refractory B-Cell Non-Hodgkin Lymphoma

Abroad (travel likely)Recruiting

Columbus, United States

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Cancer · Breast Cancer · Non-Small Cell Lung Cancer (NSCLC)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

National Longitudinal Cohort of Hematological Diseases

Multiple Myeloma · Acute Myeloid Leukemia · Hemophilia

Abroad (travel likely)Recruiting

Tianjin, China

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Brain Cancer · Breast Cancer · Bladder Cancer

Abroad (travel likely)Recruiting

Duarte, United States · Miami, United States